Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: A clue to pathogenesis?

AIDS

Volumn 21, Issue 3, 2007, Pages 383-384

  Lipman, Marc C I ^a   Carding, Sally K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; LOPINAVIR; MONTELUKAST; PREDNISOLONE; RANITIDINE; SAQUINAVIR;

ADULT; ARTICLE; BLOOD EXAMINATION; CASE REPORT; DRUG INDUCED DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; PATHOGENESIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SERODIAGNOSIS; URTICARIAL VASCULITIS; VASCULITIS;

ACETATES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM DISEASES; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; QUINOLINES; SYNDROME;

EID: 33846625205     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328011cb38     Document Type: Article

References (8)

1. Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 8:213-227.
2. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5:361-373.
3. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18:1615-1627.
4. Mayanja-Kizza H, Jones-Lopez E, Okwera A, Wallis RS, Ellner JJ, Mugerwa RD, et al. Uganda-Case Western Research Collaboration. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. J Infect Dis 2005; 191:856-865; E-pub 8 February 2005.
5. White D, Hardwick C, Morris E, Monteiro EF, Breen RA, Lipman MCI. Montelukast in the treatment of HIV associated immune reconstitution disease. Sex Trans Infect 2006; in press.
6. Price P, Mathiot N, Kreuger R, Stone S, Keane NM, French MA. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001; 22:279-287.
7. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: unappreciated mediators of innate immune responses. J Immunol 2005; 174:589-594.
8. Coffey MJ, Phare SM, Kazanjian PH, Peters-Golden M. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J Immunol 1996; 157:393-399.